Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Abstract

BACKGROUND The identification of novel biomarkers for early breast cancer detection would be a great advance. Because of their role in tumorigenesis and stability in body fluids, microRNAs (miRNAs) are emerging as a promising diagnostic tool. Our aim was to identify miRNAs deregulated in breast tumors and evaluate the potential of circulating miRNAs in breast cancer detection. METHODS We conducted miRNA expression profiling of 1919 human miRNAs in paraffin-embedded tissue from 122 breast tumors and 11 healthy breast tissue samples. Differential expression analysis was performed, and a microarray classifier was generated. The most relevant miRNAs were analyzed in plasma from 26 healthy individuals and 83 patients with breast cancer (36 before and 47 after treatment) and validated in 116 healthy individuals and 114 patients before treatment. RESULTS We identified a large number of miRNAs deregulated in breast cancer and generated a 25-miRNA microarray classifier that discriminated breast tumors with high diagnostic sensitivity and specificity. Ten miRNAs were selected for further investigation, of which 4 (miR-505-5p, miR-125b-5p, miR-21-5p, and miR-96-5p) were significantly overexpressed in pretreated patients with breast cancer compared with healthy individuals in 2 different series of plasma. MiR-505-5p and miR-96-5p were the most valuable biomarkers (area under the curve 0.72). Moreover, the expression levels of miR-3656, miR-505-5p, and miR-21-5p were decreased in a group of treated patients. CONCLUSIONS Circulating miRNAs reflect the presence of breast tumors. The identification of deregulated miRNAs in plasma of patients with breast cancer supports the use of circulating miRNAs as a method for early breast cancer detection.

DOI: 10.1373/clinchem.2015.238691

6 Figures and Tables

0200400201520162017
Citations per Year

433 Citations

Semantic Scholar estimates that this publication has 433 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Matamala2015TumorME, title={Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.}, author={Nerea Matamala and Mar{\'i}a Teresa Vargas and Ricardo Gonz{\'a}lez-C{\'a}mpora and Rebeca Mi{\~n}ambres and Jos{\'e} Ignacio Arias and Primitiva Men{\'e}ndez and Eduardo Andr{\'e}s-Le{\'o}n and Gonzalo G{\'o}mez-L{\'o}pez and Kira Yanowsky and Julio Calvete-Candenas and Luc{\'i}a Inglada-P{\'e}rez and Beatriz Mart{\'i}nez-Delgado and Javier J Benitez}, journal={Clinical chemistry}, year={2015}, volume={61 8}, pages={1098-106} }